Announcements Trials
Browse Landscape

Phase

Phase NA 34Phase 2 26Phase 3 14Phase 1/2 4Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Gastrointestinal 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Mastectomy, Segmental × Clear all
NCT07217990 2026-02-17

NoCUT-BC

Ohio State University Comprehensive Cancer Center

Phase 1/2 Not yet recruiting
84 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

Radboud University Medical Center

Phase 1/2 Unknown
20 enrolled
Gastrointestinal

Pancreatic Neoplasms, Rectal Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Albert Einstein College of Medicine

Phase 1/2 Completed
55 enrolled 10 charts
Breast

Breast Neoplasms

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡